可光激活的,针对线粒体的dppz (III) 复合物选择性地相互作用并损害癌细胞中的线粒体DNA
Jana Kasparkova1, Vojtech Novohradsky2, José Ruiz3
1Department of Biophysics, Faculty of Science, Palacky University, CZ-783 71, Olomouc, Czech Republic.
Chemico-biological interactions
|February 21, 2024
概括
这项研究表明,循环金属化III复合物 (Ir1) 向癌细胞线粒体,结合并破坏线粒体DNA (mtDNA). 蓝光通过促进DNA裂变来增强其抗癌作用,这表明了一种新的光疗策略.
科学领域:
- 有机金属化学 有机金属化学
- 摄影化学的使用.
- 癌症生物学 癌症生物学
- 线粒体生物学 线粒体生物学
背景情况:
- 循环金属化 (III) 复合物显示出作为抗癌剂的前景.
- 这种二氧化[3,2-a:2',3'-c]phenazine (dppz) 连接体表明了潜在的DNA相互作用.
- 线粒体是关键的细胞器官和癌症治疗的潜在目标.
研究的目的:
- 为了研究循环金属化伊 (III) 复合物[Ir(L) 2 ((dppz) ]PF6 (Ir1) 的抗癌机制.
- 确定Ir1.1的细胞定位和DNA结合特性.
- 探索蓝光辐射对Ir1活动和DNA相互作用的影响.
主要方法:
- 在癌细胞中进行细胞积累研究.
- 线粒体DNA (mtDNA) 的结合测试.
- DNA结合研究 (无细胞),包括序列偏好和结合模式分析.
- 在蓝光辐射下进行DNA裂变检测.
- 线粒体编码的基因转录分析.
主要成果:
- 在癌细胞线粒体中积聚Ir1并选择性地结合mtDNA.
- 艾尔1抑制了线粒体编码的基因的转录,由蓝光增强.
- 伊尔1以槽结合方式结合DNA,更喜欢富含GC的序列.
- 在蓝光照射时,Ir1诱导DNA裂变,可能是通过超氧化基的产生.
- mtDNA损伤显著促进了Ir1的抗瘤功效.
结论:
- 艾尔1是一种强大的抗癌剂,向线粒体DNA.
- 使用Ir1进行蓝光光疗法可以增强其对DNA的破坏性和抗瘤作用.
- 针对线粒体基因组使用可光激活的 (Iridium) 复合体是一个可行的抗癌策略.
相关概念视频
Electron Transport Chain: Complex I and II
13.3K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
13.3K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Mutations
37.5K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
37.5K
DNA Damage can Stall the Cell Cycle
9.2K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K
The Intrinsic Apoptotic Pathway
6.5K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K


